# Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

> **NCT00043888** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 60 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** fosamprenavir
- **DRUG:** COMBIVIR
- **DRUG:** ritonavir
- **DRUG:** TRIZIVIR

## Key facts

- **NCT ID:** NCT00043888
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 60 (—)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043888, "Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00043888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*